Annual Conference Speakers
Dr. Rudolf Bauer
Rudolf Bauer studied Pharmacy at the Ludwig-Maximilians Universität in Munich where he also obtained his PhD and wrote his habilitation. From 1993 until 2002 he was Professor at the University of Dusseldorf in Germany, before moving to Austria, where he is now Head of the Institute of Pharmaceutical Sciences at the University of Graz. His research focuses on Traditional Chinese Medicine, inflammation processes, plant metabolomics, screening and structure elucidation of plant active ingredients, quality control for herbal medicine, and activity and phytochemistry of Echinacea species. He has published more than 370 research papers and several books. He has been awarded, among others, the Egon-Stahl-Award of the Society for Medicinal Plant Research, the International Award of the Belgian Society of Pharmaceutical Sciences and the Norman R. Farnsworth Excellence in Botanical Research Award of the American Botanical Council.
Dr. Bruno David
Director Natural Substances, R&D Sourcing & Botany at Pierre Fabre Research Institute
Bruno David is a pharmacist and chemist by training (DPharm from Dijon University and PhD in Phytochemistry from CNRS ICSN Gif sur Yvette, and Pharmacology from CNRS IPBS Toulouse (Pharmacology and Toxicology Laboratory). He began his career as a visiting lecturer at the University Malaya and as a lecturer at the Faculty of Pharmacy at Paris XI.
Bruno joined Pierre Fabre Pharmaceutical Group in 1990 to lead the phytochemistry group. Between 1998 and 2007, he was in charge of the Natural Products Drug Discovery joint team (Pierre Fabre Research Institute/CNRS/IRD) involved in High Throughput Screening. Since 2007, he has been the Director of Natural Products, R&D Sourcing & Botany. Member of the French National Academy of Pharmacy and of many scientific associations, he has coauthored more than 60 publications, books and patents. He also obtained the University Professor Habilitation in 2000. He is also active in the field of Biodiversity and legal certainty (Member of the Strategic Orientation Council of the Foundation for Research on Biodiversity) and of many professional federations and groups dealing with biodiversity Access and Benefit Sharing (ABS) issues (LEEM, FEBEA, Cosmetics Europe, UNITIS…). He acts also an ABS expert for the French Ministry of Research and the European Commission.
Dr. Dugald Seely
Ottawa Integrative Cancer Centre, University of Ottawa
Dugald Seely is a naturopathic doctor and clinician scientist whose focus is on the application and evaluation of integrative oncology. Embodying a synthesis of evidence based complementary medicine with conventional medicine, integrative oncology offers a path for improved clinical care that is obvious to the conscientious practitioner and that best supports patients in the way they most need. Dr. Seely seeks to build a richer integration of this medicine within the health care system as a respected path for practitioners and researchers and ultimately for patients to be best served.
Dr. Seely is the founder and executive director of the Ottawa Integrative Cancer Centre (OICC) and executive director for the department of research & clinical epidemiology at the Canadian College of Naturopathic Medicine. Dr. Seely is an affiliate investigator at the Ottawa Hospital Research Institute; Adjunct Professor with the Faculty of Medicine at the University of Ottawa; Integrative Oncology Section Editor for the journal Current Oncology; and Vice President of the Oncology Association of Naturopathic Physicians. In research, Dr. Seely has led numerous clinical studies and synthesis reviews having published over 70 peer-reviewed papers. Seely is a frequent speaker and is actively engaged in the research community through a number of associations. In clinic, Dr. Seely sees patients three days a week at the OICC and is thrilled to be able to combine his passion for research and in the service of the patients he cares for.